PRTA - PROTHENA CORP PUBLIC LTD CO
9.86
0.500 5.071%
Share volume: 525,015
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$9.36
0.50
0.05%
Summary score
24%
Profitability
0%
Dept financing
30%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.33%
Return on assets
-7.79%
Return on sales
0%
Return on invested capital
-136.76%
Total debt ratio
16.91%
Debt ratio change over timeo
0%
Current Ratio
12.19%
Quick Ratio
0%
Cash Position Ratio
10.24%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.97%
Return on assets
-7.51%
Return on sales
0%
Return on invested capital
-130.96%
Total debt ratio
17.05%
Debt ratio change over timeo
0%
Current Ratio
12.42%
Quick Ratio
0%
Cash Position Ratio
9.42%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-11.74%
Return on assets
-9.96%
Return on sales
0%
Return on invested capital
-178.47%
Total debt ratio
17%
Debt ratio change over time
0%
Current Ratio
11.95%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRTA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -9.33% | 4.12% | 5.6% | 28.84% |
| Return on assets | -7.79% | 2.87% | 3.58% | 3.88% |
| Return on sales | 0% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | -136.76% | 4.34% | 6.5% | 4.27% |
| Profitability | 0% | 52% | 72% | 91% |
| Total debt ratio | 16.91% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 17% | 14% | 25% |
| Current Ratio | 12.42% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 9.42% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 18% | 31% | 26% |
| Short-term ratios | PRTA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -8.97% | 3.9% | 5.53% | 29.97% |
| Return on assets | -7.51% | 2.93% | 3.51% | 3.83% |
| Return on sales | 0% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | -130.96% | 4.21% | 6.14% | 4.25% |
| Profitability | 0% | 53% | 71% | 92% |
| Total debt ratio | 17.05% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 18% | 14% | 25% |
| Current Ratio | 12.42% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 9.42% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 19% | 30% | 27% |